INDIAZydus Gets SEC Nod For Trials of Covid-19 AntibodyNileshJune 4, 2021June 4, 2021 by NileshJune 4, 2021June 4, 202101108 Pharmaceuticals major Zydus Cadila has received permission from the Subject Expert Committee (SEC) to conduct clinical trials of its monoclonal antibodies (mAbs) based cocktail for...